...
首页> 外文期刊>Neuroscience: An International Journal under the Editorial Direction of IBRO >ALPHA2-ADRENOCEPTOR-INDEPENDENT INHIBITION OF ACETYLCHOLINE RECEPTOR CHANNEL AND SODIUM CHANNEL BY DEXMEDETOMIDINE IN RAT SUPERIOR CERVICAL GANGLION NEURONS
【24h】

ALPHA2-ADRENOCEPTOR-INDEPENDENT INHIBITION OF ACETYLCHOLINE RECEPTOR CHANNEL AND SODIUM CHANNEL BY DEXMEDETOMIDINE IN RAT SUPERIOR CERVICAL GANGLION NEURONS

机译:右美托咪定对大鼠上颈神经节神经元的乙酰胆碱受体通道和钠通道的α2-肾上腺素受体依赖性抑制

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Both central and peripheral sympathetic nervous systems contribute to the cardiovascular effects of dexmedetomidine (DMED), a highly selective and widely used a(2)-adrenoceptor agonist for sedation, analgesia, and stress management. The central sympatholytic effects are augmented by peripheral inhibition of sympathetic ganglion transmission. The mechanism is not clear. In this research, using conventional patch-clamp recordings we investigated the direct effects of DMED on sodium (Na+) channel currents (I-Na) and nicotinic acetylcholine (ACh) receptor (nAC-hRs) channel currents (I-ACh) in rat superior cervical ganglion (SCG) neurons to explore the possible mechanisms of sympathetic ganglion transmission inhibition by DMED. DMED voltage-dependently suppressed INa with half maximal inhibitory concentration (IC50) values of 67.2 +/- 9.6 mu M and 26.1 +/- 5.3 mu M at holding potentials of -80 mV and -60 mV, respectively. The inhibition of Na+ channels by DMED was also frequency dependent. 100 lM DMED shifted the Na+ channel inactivation curves to the hyperpolarizing direction by 9.8 mV (P < 0.01) and slowed the recovery from inactivation by 8.9 ms (P < 0.01), but no effects were seen on the shape of the current-voltage relationship or Na+ channels activation curves. DMED dose-dependently inhibited I-ACh with an IC50 value of 5.5 +/- 2.4 mu M in SCG neurons, and this inhibition was voltage-independent. DMED pretreatment followed by fast co-application of DMED and ACh produced a significantly larger IACh inhibition than without DMED pretreatment. Yohimbine, phentolamine, and atropine pretreatment did not alter the inhibitory effects of DMED on INa and I-ACh. In conclusion, DMED dose-dependently inhibits I-Na and I-ACh in rat SCG neurons by preferential binding to the inactivated state of the Na+ channels and the closed state (resting) of nAChR channels respectively. Both inhibitions are a(2)-adrenoceptor independent. Furthermore, the nAChR channels in rat SCG neurons are much more sensitive to inhibition by DMED than Na+ channels. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.
机译:中枢和外周交感神经系统都有助于右美托咪定(DMED)的心血管作用,右美托咪定是一种高度选择性且广泛使用的a(2)-肾上腺素受体激动剂,用于镇静,镇痛和缓解压力。外周交感神经节传递的抑制作用增强了中央交感神经作用。机制尚不清楚。在这项研究中,我们使用常规的膜片钳记录研究了DMED对大鼠钠(Na +)通道电流(I-Na)和烟碱型乙酰胆碱(ACh)受体(nAC-hRs)通道电流(I-ACh)的直接影响上颈神经节(SCG)神经元,探讨DMED抑制交感神经节传递的可能机制。 DMED电压依赖性抑制的INa的半最大抑制浓度(IC50)值分别为-80 mV和-60 mV,分别为67.2 +/- 9.6μM和26.1 +/- 5.3μM。 DMED对Na +通道的抑制作用还与频率有关。 100 lM DMED使Na +通道失活曲线向超极化方向移动了9.8 mV(P <0.01),并使失活的恢复速度降低了8.9 ms(P <0.01),但是对电流-电压关系的形状没有影响或Na +通道激活曲线。 DMED在SCG神经元中剂量依赖性地抑制I-ACh,IC50值为5.5 +/- 2.4μM,并且这种抑制是电压依赖性的。与不使用DMED预处理相比,DMED预处理随后快速共同应用DMED和ACh产生了更大的IACh抑制作用。育亨宾,酚妥拉明和阿托品预处理均未改变DMED对INa和I-ACh的抑制作用。总之,DMED通过分别优先结合Na +通道的失活状态和nAChR通道的闭合状态(静止)来剂量依赖性地抑制大鼠SCG神经元中的I-Na和I-ACh。两种抑制都是独立于a(2)-肾上腺素能受体的。此外,与Na +通道相比,大鼠SCG神经元中的nAChR通道对DMED抑制更为敏感。 (C)2015年IBRO。由Elsevier Ltd.出版。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号